Sysmex (6869) Fundamentals 2026 — P/E 27.2x, Revenue Analysis | SniperIQ
Sysmex (6869) is a JP-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of ¥937.5B, trading at ¥1549.00 on the JPX. This SniperIQ fundamentals page covers Sysmex's valuation (P/E 27.2x, P/B 1.9x), profitability (net margin 7.1%), revenue (¥500.0B in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Sysmex's market cap?
Sysmex (6869) has a market capitalization of approximately ¥937.5B, trading at ¥1549.00 on the JPX. Market cap moves with the live share price.
What is Sysmex's P/E ratio?
Sysmex's trailing twelve-month P/E ratio is 27.2x, with a price-to-book (P/B) of 1.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Sysmex?
Sysmex runs a net profit margin of 7.1%, a gross margin of 51.1%, and an operating margin of 12.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Sysmex generate?
Sysmex reported revenue of ¥500.0B for fiscal year 2026, with net income of ¥35.5B and earnings per share (EPS) of 56.89. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Sysmex pay a dividend?
Sysmex offers a trailing dividend yield of about 2.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Sysmex financially healthy?
Sysmex carries a debt-to-equity ratio of 0.14x and a current ratio of 3.26x, with a market beta of 0.68. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Sysmex a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Sysmex (6869) the key facts are: market cap ¥937.5B, P/E 27.2x, revenue ¥500.0B, 52-week range 1246-2563.5. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Sysmex's full fundamentals live
Get Sysmex's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.